Risedronate therapy for prevention of hip fracture after stroke in elderly women; Risedronate therapy for prevention of hip fracture after stroke in elderly women. Reply from the Authors
Citation Manager Formats
Make Comment
See Comments

The Neurology® editorial office recently received a letter expressing concern about the validity of the results of this paper.1 The corresponding author, Dr. Yoshihiro Sato, responded to a request for an explanation by requesting that the paper be retracted because of scientific misconduct. Dr. Sato accepts full responsibility for this fraudulent paper and maintains that none of the coauthors participated in any misconduct and appeared as authors on an honorary basis only. The Editor retracts online and printed replies related to the article.2,3
- © 2016 American Academy of Neurology
REFERENCES
- 1.↵
- 2.↵
- Sato Y,
- Iwamoto J,
- Kanoko T,
- Satoh K
- 3.↵
- Sato Y,
- Iwamoto J,
- Kanoko T,
- Satoh K
Letters: Rapid online correspondence
- Editor response to Dr. Kappos
- Robert A. Gross, Editor-in-Chief (2009-present), Neurology journals, Strong Epilepsy Center, University of Rochester Medical Center[email protected]
- Robert C. Griggs (EIC 1997-2007), Rochester, NY
Submitted September 01, 2016 - Introducing honorary authorship
- Ludwig Kappos, Professor and Chair, Neurology, University Hospital Basel[email protected]
Submitted September 01, 2016
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
WriteClick® Editor's Choice
Editor Response: Retraction: Risedronate Therapy For Prevention Of Hip Fracture After Stroke In Elderly Women; Risedronate Therapy For Prevention Of Hip Fracture After Stroke In Elderly Women: Reply From The AuthorsRobert A. Gross, Robert C. Griggs et al.Neurology, January 09, 2017 -
Retraction
Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson diseaseet al.Neurology, July 11, 2016 -
Editorial
Statistics and the detection of scientific misconductRobert A. Gross, Editor-in-Chief et al.Neurology, November 09, 2016 -
Article
Systematic review and statistical analysis of the integrity of 33 randomized controlled trialsMark J. Bolland, Alison Avenell, Greg D. Gamble et al.Neurology, November 09, 2016